 OPPORTUNITIES AND BARRIERS IN THE BIOSIMILAR MARKET:
Biopharmaceutical drugs (or biologics) have outperformed the pharmaceutical market as a whole largely due to two factors: they address areas of clinical need that are unmanageable with conventional therapeutics (including many cancers and genetic diseases) and they are able to command a premium price. More...
PricewaterhouseCoopers Report on the Japan Pharmaceutical Market - "Japan prescription for growth". More>>
 ABLE and Bio
Spectrum are pleased to bring you the results of THE FIFTH SURVEY on Indian Biotech Industry.
Click here to read the Fourth surveyClick here to read the Third surveyClick here to read the Second surveyClick here to read the First survey
Department of Biotechnology, Ministry of Science and Technology, Government of India has launched the SBIRI – Small Business Innovation Research Initiative.
Destination India:
Read NewScientist's special section on India
Read BioCentury's Cover Story on Doing Business in India.
|
| ABLE Budget Meeting |
 |
| ABLE organised a brainstorming session by CEOs/CFOs of the Indian biotech industry to finalise budget recomendations for the new year. The meeting was held at the India Habitat Centre, New Delhi on 23 January '08. |
BIOTECanada - ABLE MOU
ABLE amd BIOTECanada, signed a MOU to strive for closer cooperation in the Biotech sector between the two countries.
The agreement was signed at BIOTECanada’s booth at BIO 2006 in Chicago on 10th April , by Dr. Narayanan, MD, Metahelix Life Sciences and President of ABLE & Mr. Peter Brenders, President of BIOTECanada .
ABLE signs MoU with IBIA
» ABLE has signed a MoU with the Irish Bioindustry Association to improve collaboration in the Biotech sector. For more details, visit the following links:
www.ibec.ie
www.pharmachemicalireland.ie
www.ibia.ie
The agreement is expected to open up potential partnerships in research and commerce.
Partnering Opportunities with New Zealand Biotech Companies
» ABLE met with a delegation from Investment New Zealand to exchange information about the biotech industry in India and New Zealand.
Download PPT (1 MB) of a presentation titled "Biotechnology Opportunities in New Zealand" by Dr. Bret A M Morris, Investment Manager - Biotechnology, Investment New Zealand, New Zealand Trade and Enterprise.
ABLE and AusBiotech sign MoU
ABLE and AusBiotech have signed a MOU to provide a common platform for Indian and Australian companies, academic and research institutions. Contact us for more info.
ABLE Builds Linkages with Japan
» ABLE met with
leaders of the Japanese Biotech Industry & Research Institutions
and marketed the Indian Biotech Sector. More info & downloads.
» Explore business opportunities in Japan through ABLE.
» Contact us for more info.
|
